News | December 04, 2014

Chesapeake Urology Improves Prostate Cancer Detection and Diagnosis With 3-D Ultrasound/MRI Fusion Biopsy

More than 500 prostate biopsies have been performed utilizing this technology

biopsy systems, prostate, 3-d technology

December 4, 2014 — Chesapeake Urology Associates offers a state-of-the-art prostate cancer diagnostic, which fuses detailed MRI scans with live, real-time ultrasound images of the prostate. This biopsy system provides Chesapeake urologists with the capability to pinpoint tumors within the prostate gland, leading to more targeted treatment planning and better outcomes.

By combining advanced MRI imaging with 3-D ultrasound technology, this new biopsy system:

  • Creates a 3-D map of the prostate
  • Identifies suspicious lesions or targets on MRI
  • Fuses or overlaps the 3-D MRI image onto the real-time 3-D ultrasound image of the prostate
  • Provides clear visualization of the biopsy needle and the targeted lesion for accurate guidance
  • Stores the exact location of each biopsy sample for future referencebopsy

 

Unlike the standard 2-D TRUS-guided prostate biopsy, which takes random tissue samples from the prostate and has a higher rate of missing cancerous cells within the gland, the 3-D Ultrasound/MRI Fusion Biopsy combines the clarity of an MRI image with a 3-D ultrasound image. This creates an enhanced 3-D map of the prostate for improved visualization of the gland, allowing determination of the exact location of potential tumors.

For more information: www.chesapeakeurology.com

Related Content

Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program
News | Prostate Cancer | June 14, 2018
Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
New Studies Highlight MRI Use for Prostate Cancer Screening and Management
News | Magnetic Resonance Imaging (MRI) | May 21, 2018
Three new studies presented at the 113th annual meeting of the American Urological Association (AUA) highlight the...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
USPSTF Updates Recommendations for Prostate Cancer Screening
News | Prostate Cancer | May 09, 2018
The U.S. Preventive Services Task Force (USPSTF) posted a final recommendation statement and evidence summaries on...
Shorter Radiotherapy Courses Safe and Effective for Prostate Cancer
News | Prostate Cancer | April 23, 2018
Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate cancer patients,...
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
Overlay Init